Navigation Links
Reliv’s LunaRich Earns Ingredient Patent

Chesterfield, MO (PRWEB) August 08, 2013

Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich® has earned a new patent from the US Patent and Trademark Office. The composition of matter patent protects the LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy’s documented health benefits.

“This is an exciting step forward for Reliv and for our LunaRich product line,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “We already owned a patent for LunaRich’s ability to reduce LDL cholesterol. Now we have added a patent for the LunaRich material itself. The result is a very strong patent portfolio for a remarkable nutritional ingredient.”

The patent announcement comes only two weeks after Reliv entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. The license covers a previously issued patent and several patent applications (one now granted) related to lunasin and soy-related peptides, proprietary information and manufacturing processes.

LunaRich’s Superior Bioavailability

The amount of lunasin in soybeans varies significantly based on seed, soil and environment. LunaRich uses specially selected soybeans grown exclusively for Reliv with highly concentrated levels of bioactive lunasin.

LunaRich’s unique refinement process retains a more uniform and integrated “shell” of protease inhibitors, which serve as protective chaperone molecules to better protect the lunasin from being destroyed in the stomach. The shell is then broken down to allow for maximum absorption of lunasin in the small intestine, where it can provide the greatest benefit. Learn more about LunaRich's bioavailability.

“We have demonstrated through our exclusive bioassay, based on lunasin's proprietary epigenetic mechanism of action, that LunaRich products maintain lunasin’s bioactivity after digestion,” said Dr. Alfredo Galvez, lead scientific advisor at SL Technologies, a Reliv subsidiary. “It is the only test of its kind in the supplement industry and gives Reliv the unique ability to guarantee the bioavailability of lunasin in its LunaRich products. Now we have a patent to protect the novel formulations that make LunaRich products so effective in providing all the health benefits of lunasin." Learn more about the benefits of lunasin.

How Lunasin Works

Lunasin is one of the first nutritional compounds identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means “beyond the genome,” is a higher level of complexity within the cell. It acts like a dimmer for lights, controlling which genes are used, when they are used and how much they are used.

Lunasin can attach itself to the epigenome. As a result, it can increase expression of important genes needed for normal cell functioning and protect the cells from environmental damage once it occurs. More than 50 published papers from more than 25 research institutions demonstrate lunasin’s multiple health benefits. Learn more about lunasin and epigenetics.

In addition to the LunaRich patents, nine Reliv nutritional formulas have earned US patents: Reliv Classic® for essential daily nutrition, Innergize!® for isotonic hydration, FibRestore® for digestive health, Cellebrate® for weight loss, Arthaffect® for joint health, ReversAge® for anti-aging, GlucAffect® for blood sugar management, ProVantage® for performance nutrition and 24K™ for healthy energy. Note: the patents for Reliv Classic and Innergize! have expired.

About Reliv International, Inc.

Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at, or on Facebook, Twitter or YouTube.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Reliv’s LunaRich X Named Finalist for 2013 American Business Awards
2. Louisiana Tech University professor earns NSF Early Career Development grant
3. Cedars-Sinai stroke team earns award for improving regions quality of care
4. Louisiana Tech biomedical engineering professor earns recognition, funding for research
5. Macho Men Do Worse in Couples When the Woman Earns More
6. Kolanowski earns GSAs 2012 Doris Schwartz Gerontological Nursing Research Award
7. Hoppmann earns GSAs 2012 Baltes Foundation Award
8. Beck earns GSAs 2012 M. Powell Lawton Award
9. Naylor earns GSAs 2012 Maxwell A. Pollack Award for Productive Aging
10. Crimmins earns GSAs 2012 Robert W. Kleemeier Award
11. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, ... organization dedicated to helping service members that have been wounded in battle and their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery Institute ( ... as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, owns ... Dr. Olson says the decision to support the pageant in an official capacity ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology: